Key result
In an in vitro model, combining IABP with ECMO increased coronary mean blood flow by 3.4% to 16% at a heart rate of 60 bpm, with greater benefits observed at lower heart rates and less severe heart failure.
Why the study?
Combining IABP with ECMO is believed to increase coronary artery flow and restore pulsatile flow, but its effect during various load conditions required evaluation.
Does combining IABP with ECMO improve coronary artery blood flow in simulated heart failure conditions?
Does combining IABP with ECMO improve coronary artery blood flow in simulated heart failure conditions?
In an in vitro model, combining IABP with ECMO improved coronary blood flow, particularly at lower heart rates, suggesting a potential benefit for recovery from cardiac failure.
Hypothesis-generating for IABP-ECMO in LV failure; prospective trials required before any clinical consideration.
ECMO is the most frequently used mechanical support for patients suffering from low cardiac output syndrome. Combining IABP with ECMO is believed to increase coronary artery blood flow, decrease high afterload, and restore systemic pulsatile flow conditions. This study evaluates that combined effect on coronary artery flow during various load conditions using an in vitro circuit. In doing so, different clinical scenarios were simulated, such as normal cardiac output and moderate-to-severe heart failure. In the heart failure scenarios, we used peripheral ECMO support to compensate for the lowered cardiac output value and reach a default normal value. The increase in coronary blood flow using the combined IABP-ECMO setup was more noticeable in low heart rate conditions. At baseline, intermediate and severe LV failure levels, adding IABP increased coronary mean flow by 16%, 7.5%, and 3.4% (HR 60 bpm) and by 6%, 4.5%, and 2.5% (HR 100 bpm) respectively. Based on our in vitro study results, combining ECMO and IABP in a heart failure setup further improves coronary blood flow. This effect was more pronounced at a lower heart rate and decreased with heart failure, which might positively impact recovery from cardiac failure.
No takes yet. Share an insight, caveat, or question.
Reymond et al. (2021) studied Low cardiac output syndrome (simulated). Intra-Aortic Balloon Pump (IABP) combined with ECMO vs. ECMO alone (without IABP) was evaluated on Coronary mean blood flow. In an in vitro model, combining IABP with ECMO increased coronary mean blood flow by 3.4% to 16% at a heart rate of 60 bpm, with greater benefits observed at lower heart rates and less severe heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: